William E Rosenfeld

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Chronic Kidney Disease

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Louis Ferrari, William E Rosenfeld, Marc Kamin
A global update on cenobamate based on real-world experience in over 100 000 patients. Epilepsia 65 (4) (2024)
Louis Ferrari, William E Rosenfeld, Marc Kamin
A global update on cenobamate based on real-world experience in over 100 000 patients. Epilepsia 65 (4) (2024)
Louis Ferrari, William E Rosenfeld, Marc Kamin
A global update on cenobamate based on real-world experience in over 100 000 patients. Epilepsia (2024)
David G Vossler, William E Rosenfeld, Sean Stern, Clarence T Wade, Louis Ferrari, Wesley T Kerr, Robert Wechsler
Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post-hoc analysis of a phase 3, open-label study. Epilepsia (2023)
William E Rosenfeld, Louis Ferrari, Wesley T Kerr, Mickael R Sperling
Sudden unexpected death in epilepsy during cenobamate clinical development. Epilepsia (2023)
Jacqueline A French, Steve S Chung, Gregory L Krauss, Sang Kun Lee, Maciej Maciejowski, William E Rosenfeld, Mickael R Sperling, Marc Kamin
Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study. Epilepsia 62 (9) (2021)
Josemir W Sander, William E Rosenfeld, Jonathan J Halford, Bernhard J Steinhoff, Victor Biton, Manuel Toledo
Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program. Epilepsia (2021)
William E Rosenfeld, Bassel Abou-Khalil, Sami Aboumatar, Perminder Bhatia, Victor Biton, Gregory L Krauss, Mickael R Sperling, David G Vossler, Pavel Klein, Robert T Wechsler
Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications. Epilepsia 62 (12) (2021)
Mickael R Sperling, Bassel Abou-Khalil, Sami Aboumatar, Perminder Bhatia, Victor Biton, Pavel Klein, Gregory L Krauss, David G Vossler, Robert T Wechsler, Louis Ferrari, Mindy Grall, William E Rosenfeld
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study. Epilepsia 62 (12) (2021)